Novartis works with the patient community around the world to discover new ways to improve and extend people’s lives. Our significant investment in research and development underpins our commitment to using science-based innovation to address some of society's most challenging healthcare issues. Only by working together can we improve outcomes for patients and change the practice of medicine.

Patient organizations representing


Patients contributed to its development

108 514

Novartis associates own it as an aspiration

Download 2021 Factsheet (PDF 0.1 MB)

The Novartis Commitment to Patients and Caregivers

We recognize the importance of patients and caregivers understanding what they can expect from Novartis.

The four pillars of our Commitment

Icon of a handshake

Respecting and understanding the patient community perspective

Icon of a globe

Expanding access to our medicines

Icon of a stethoscope

Conducting responsible clinical trials

Icon of a magnifying glass

Recognizing the importance of transparency and reporting

Transmission electron microscopic image of an isolate from a case of COVID-19

Patients and Caregivers COVID-19 Information

Novartis is working to ensure supply of our medicines, enhance virtual services, protect the integrity of clinical trials and support patient organizations during the COVID-19 pandemic.

doctor and nurse

Disclosure of patient organization funding

Novartis annually discloses monetary and non-monetary support to patient organizations around the globe by June 30.

Our Commitment – reporting 2021 progress

Early research programs

in general medicines obtained patient insights before first-in-human trials (healthy volunteers). Piloted patient panels for five Proof of Concept indications.

8 092
Patients reached through managed access programs

95% requests approved for 62 compounds in 95 countries - providing pre-approval access to Novartis medicines. At the end of  2021, more  than  13 000 patients were  receiving  treatment through  MAPs.

Clinical development programs

comprising 70 clinical trials, had a patient engagement component to obtain the patient perspective on the design and/or conduct of clinical trials.

Clinical trials

included Patient Reported Outcomes (PRO) conducted in 72 countries.

Simplified summaries

from Phase 1-4 clinical trials sent to investigators to share with 27 013 trial participants and posted on


reached through access approaches.

Clinical Trials

Collaborations with Patient Organizations

A woman, accompanied by her caregiver, shares her experiences with a doctor.

Sound up for lung cancer research

Global Oncology Patient Insights Panels (GOPIPs) are giving patients and advocates a critical voice in advancing lung cancer trials.

patients caregivers award

Novartis ranks #4 in PatientView’s 2019 corporate reputation survey of patient organizations worldwide

The Corporate Reputation of Pharma 2019 global report reflects the findings of a survey conducted by PatientView with patient organization worldwide

Patient Organizations and Novartis

We collaborate with patient organizations and healthcare organizations globally in the disease areas for which we provide or are developing medicines. This collaboration is based on values of mutual respect, trust and transparency.

men handshake_0

External Funding

Novartis may provide funding to legitimate organizations to support its mission to discover new ways to improve and extend people's lives, advancing scientific and medical knowledge, and supporting the communities where Novartis Associates live and work.

mother daughter hug

Patient Perspectives

We commit to actively seeking out and listening to insights from the patient community. Visit our YouTube channel to watch our Patient & Caregiver stories and learn more about our resources.

For questions about Novartis, medical inquiries about our products and/or information about services, we recommend you contact the Novartis office in your country. If you’re seeking a global list of products, visit our Global Product Portfolio.